Publications by authors named "D Dimulescu"
Article Synopsis
- Dapagliflozin has shown to improve heart failure and kidney-related outcomes in patients with type 2 diabetes, particularly in those with or at high risk for cardiovascular disease, as demonstrated in the DECLARE-TIMI 58 trial.
- The trial involved 17,160 patients and assessed the medication's effects based on different levels of baseline systolic blood pressure (SBP) while monitoring both efficacy outcomes (like hospitalization for heart failure) and safety outcomes (like acute kidney injury).
- Results indicated that dapagliflozin decreased SBP and its benefits for heart and kidney health were consistent across various BP categories, with no serious safety issues related to the drug compared to placebo.
Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism.
Clin Appl Thromb Hemost
March 2022
Venous thromboembolism (VTE) is a multifactorial disease that can possibly affect any part of venous circulation. The risk of VTE increases by about 2 fold in pregnant women and VTE is one of the major causes of maternal morbidity and mortality. For decades superficial vein thrombosis (SVT) has been considered as benign, self-limiting condition, primarily local event consequently being out of scope of well conducted epidemiological and clinical studies.
View Article and Find Full Text PDFNowadays, obesity is a major worldwide health problem due to its serious consequences and toits increasing prevalence. Bariatric surgery has demonstrated a sustained weight loss and an efficient long-term control of the co-morbidities associated with obesity. The objective of our study was to compare cardiovascular risk factors before and after bariatric surgery.
View Article and Find Full Text PDFAcute Myocardial Infarction Mortality Rates and Trends in Romania between 1994 and 2017.
Int J Environ Res Public Health
December 2019
The current study aimed to assess recent acute myocardial infarction (AMI) mortality rates and trends in Romania between 1994 and 2017. This dataset is a necessity in the context of the current improvement of emergency protocols, medical addressability, and modernization of hospital infrastructure. The study is a retrospective analysis of an anonymized mortality database containing all deaths registered in Romania during 1994-2017.
View Article and Find Full Text PDFObjectives: To estimate the trend in arterial hypertension's prevalence, awareness, treatment, and control in Romania, starting from the latest national survey Study for the Evaluation of Prevalence of Hypertension and Cardiovascular Risk in Romania III that has a crucial importance for the development of prevention strategies at national level.
Methods: A representative sample of 1970 Romanian adults (mean age 48.38 years, age range 18-80 years, 52.